{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T12:50:27Z","timestamp":1783774227339,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,6,6]],"date-time":"2010-06-06T00:00:00Z","timestamp":1275782400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1007\/s11060-010-0235-4","type":"journal-article","created":{"date-parts":[[2010,6,5]],"date-time":"2010-06-05T14:43:05Z","timestamp":1275748985000},"page":"101-106","source":"Crossref","is-referenced-by-count":75,"title":["Perioperative levetiracetam for prevention of seizures in supratentorial brain tumor surgery"],"prefix":"10.1007","volume":"101","author":[{"given":"Iris","family":"Zachenhofer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Donat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Oberndorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Roessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,6]]},"reference":[{"key":"235_CR1","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.seizure.2005.09.003","volume":"14","author":"B Abou-Khalil","year":"2005","unstructured":"Abou-Khalil B, Schaich L (2005) Long-term efficacy of levetiracetam for partial seizures. Seizure 14:577\u2013585","journal-title":"Seizure"},{"key":"235_CR2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/adc.57.9.681","volume":"57","author":"RD Barr","year":"1982","unstructured":"Barr RD, Copeland SA, Stockwell ML, Morris N, Kelton JC (1982) Valproic acid and immune thrombocytopenia. Arch Dis Child 57:681\u2013684","journal-title":"Arch Dis Child"},{"key":"235_CR3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1600-0404.2006.00657.x","volume":"114","author":"J Bauer","year":"2006","unstructured":"Bauer J, Ben-Menachem E, Kr\u00e4mer G, Fryze W, Da Silva S, Kasteleijn-Nolst Trenit\u00e9 DG (2006) Levetiracetam: a long-term follow-up study of efficacy and safety. Acta Neurol Scand 114:169\u2013176","journal-title":"Acta Neurol Scand"},{"key":"235_CR4","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/jnnp.67.4.474","volume":"67","author":"LF Beenen","year":"1999","unstructured":"Beenen LF, Lindeboom J, Kasteleijn-Nolst Trenit\u00e9 DG, Heimans JJ, Snoek FJ, Touw DJ, Ad\u00e8r HJ, van Alphen HA (1999) Comparative double blind clinical trial of phenytoin and sodium valproate as anticonvulsant prophylaxis after craniotomy: efficacy, tolerability, and cognitive effects. J Neurol Neurosurg Psychiatry 67:474\u2013480","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"235_CR5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1059-1311(02)00251-0","volume":"12","author":"E Ben-Menachem","year":"2003","unstructured":"Ben-Menachem E, Gilland E (2003) Efficacy and tolerability of levetiracetam during 1-year follow-up in patients with refractory epilepsy. Seizure 12:131\u2013135","journal-title":"Seizure"},{"issue":"suppl 3","key":"235_CR6","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1111\/j.1528-1157.1990.tb05858.x","volume":"31","author":"GD Cascino","year":"1990","unstructured":"Cascino GD (1990) Epilepsy and brain tumors: implications for treatment. Epilepsia 31(suppl 3):S37\u2013S44","journal-title":"Epilepsia"},{"key":"235_CR7","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/jnnp.47.10.1087","volume":"47","author":"JB Chalk","year":"1984","unstructured":"Chalk JB, Ridgeway K, Brophy T, Yelland JD, Eadie MJ (1984) Phenytoin impairs the bioavailability of dexamethasone in neurological and neurosurgical patients. J Neurol Neurosurg Psychiatry 47:1087\u20131090","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"235_CR8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1528-1157.2002.24801.x","volume":"43","author":"A Santis De","year":"2002","unstructured":"De Santis A, Villani R, Sinisi M, Stocchetti N, Perucca E (2002) Add-on phenytoin fails to prevent early seizures after surgery for supratentorial brain tumors: a randomized controlled study. Epilepsia 43:175\u2013182","journal-title":"Epilepsia"},{"key":"235_CR9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2165\/00044011-200424040-00001","volume":"24","author":"G Flesch","year":"2004","unstructured":"Flesch G (2004) Overview of the clinical pharmacokinetics of oxcarbazepine. Clin Drug Investig 24:185\u2013203","journal-title":"Clin Drug Investig"},{"key":"235_CR10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1535-7511.2009.01297.x","volume":"9","author":"NB Fountain","year":"2009","unstructured":"Fountain NB (2009) Should levetiracetam replace phenytoin for seizure prophylaxis after neurosurgery? Epilepsy Curr 9:71\u201372","journal-title":"Epilepsy Curr"},{"key":"235_CR11","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1600-0404.1993.tb04106.x","volume":"87","author":"ML Friis","year":"1993","unstructured":"Friis ML, Kristensen O, Boas J, Dalby M, Deth SH, Gram L, Mikkelsen M, Pedersen B, Sabers A, Worm-Petersen J et al (1993) Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment. Acta Neurol Scand 87:224\u2013227","journal-title":"Acta Neurol Scand"},{"key":"235_CR12","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1212\/WNL.54.10.1886","volume":"54","author":"MJ Glantz","year":"2000","unstructured":"Glantz MJ, Cole BF, Forsyth PA, Recht LD, Wen PY, Chamberlain MC, Grossman SA, Cairncross JG (2000) Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54:1886\u20131893","journal-title":"Neurology"},{"key":"235_CR13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0002-9343(89)80605-9","volume":"87","author":"SA Grossman","year":"1989","unstructured":"Grossman SA, Sheidler VR, Gilbert MR (1989) Decreased phenytoin levels in patients receiving chemotherapy. Am J Med 87:505\u2013510","journal-title":"Am J Med"},{"key":"235_CR14","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1212\/01.wnl.0000168903.09277.8f","volume":"65","author":"J Hildebrand","year":"2005","unstructured":"Hildebrand J, Lecaille C, Perennes J, Delattre JY (2005) Epileptic seizures during follow-up of patients treated for primary brain tumors. Neurology 65:212\u2013215","journal-title":"Neurology"},{"key":"235_CR15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0733-8619(05)70021-9","volume":"19","author":"KD Holland","year":"2001","unstructured":"Holland KD (2001) Efficacy, pharmacology, and adverse effects of antiepileptic drugs. Neurol Clin 19:313\u2013345","journal-title":"Neurol Clin"},{"key":"235_CR16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1528-1157.1999.tb00709.x","volume":"40","author":"B Kis","year":"1999","unstructured":"Kis B, Szupera Z, Mezei Z, Gecse A, Telegdy G, V\u00e9csei L (1999) Valproate treatment and platelet function: the role of arachidonate metabolites. Epilepsia 40:307\u2013310","journal-title":"Epilepsia"},{"key":"235_CR17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1059-1311(96)80023-9","volume":"5","author":"JM Kuijlen","year":"1996","unstructured":"Kuijlen JM, Teernstra OP, Kessels AG, Herpers MJ, Beuls EA (1996) Effectiveness of antiepileptic prophylaxis used with supratentorial craniotomies: a meta-analysis. Seizure 5:291\u2013298","journal-title":"Seizure"},{"key":"235_CR18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0090-3019(81)80054-7","volume":"16","author":"LA Lawson","year":"1981","unstructured":"Lawson LA, Blouin RA, Smith RB, Rapp RP, Young AB (1981) Phenytoin-dexamethasone interaction: a previously unreported observation. Surg Neurol 16:23\u201324","journal-title":"Surg Neurol"},{"key":"235_CR19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0090-3019(89)90067-0","volume":"31","author":"ST Lee","year":"1989","unstructured":"Lee ST, Lui TN, Chang CN, Cheng WC, Wang DJ, Heimburger RF, Lin CG (1989) Prophylactic anticonvulsants for prevention of immediate and early postcraniotomy seizures. Surg Neurol 31:361\u2013364","journal-title":"Surg Neurol"},{"key":"235_CR20","first-page":"2411","volume":"83","author":"C Liddle","year":"1998","unstructured":"Liddle C, Goodwin BJ, George J, Tappner M, Farrell GC (1998) Separate and interactive regulation of cytochrome P 450 3A4 by trijodothyronine, dexamethasone, and growth hormone in cultured hepatocytes. J Clin Endocrinol Metab 83:2411\u20132416","journal-title":"J Clin Endocrinol Metab"},{"key":"235_CR21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11060-008-9781-4","volume":"93","author":"DA Lim","year":"2009","unstructured":"Lim DA, Tarapore P, Chang E, Burt M, Chakalian L, Barbaro N, Chang S, Lamborn KR, McDermott MW (2009) Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study. J Neurooncol 93:349\u2013354","journal-title":"J Neurooncol"},{"issue":"suppl 3","key":"235_CR22","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1111\/j.1528-1157.1994.tb05938.x","volume":"35","author":"P Lloyd","year":"1994","unstructured":"Lloyd P, Flesch G, Dieterle W (1994) Clinical pharmacology and pharmacokinetics of oxcarbazepine. Epilepsia 35(suppl 3):S10\u2013S13","journal-title":"Epilepsia"},{"key":"235_CR23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11060-009-9977-2","volume":"96","author":"S Lwu","year":"2010","unstructured":"Lwu S, Hamilton MG, Forsyth PA, Cairncross JG, Parney IF (2010) Use of peri-operative anti-epileptic drugs in patients with newly diagnosed high grade malignant glioma: a single center experience. J Neurooncol 96:403\u2013408","journal-title":"J Neurooncol"},{"key":"235_CR24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11060-005-9070-4","volume":"78","author":"M Maschio","year":"2006","unstructured":"Maschio M, Albani F, Baruzzi A, Zarabla A, Dinapoli L, Pace A, Pompili A, Carapella CM, Occhipinti E, Jandolo B (2006) Levetiracetam therapy in patients with brain tumour and epilepsy. J Neurooncol 78:99\u2013102","journal-title":"J Neurooncol"},{"issue":"1","key":"235_CR25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11060-009-0069-0","volume":"98","author":"M Maschio","year":"2009","unstructured":"Maschio M, Dinapoli L, Gomellini S, Ferraresi V, Sperati F, Vidiri A, Muti P, Jandolo B (2009) Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy. J Neurooncol 98(1):109\u2013116","journal-title":"J Neurooncol"},{"key":"235_CR26","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/01.wnl.0000324624.52935.46","volume":"71","author":"TA Milligan","year":"2008","unstructured":"Milligan TA, Hurwitz S, Bromfield EB (2008) Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery. Neurology 71:665\u2013669","journal-title":"Neurology"},{"issue":"suppl 8","key":"235_CR27","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1111\/j.1528-1167.2009.02235.x","volume":"50","author":"S Mintzer","year":"2009","unstructured":"Mintzer S, Mattson RT (2009) Should enzyme-inducing antiepileptic drugs be considered first-line agents? Epilepsia 50(suppl 8):S42\u2013S50","journal-title":"Epilepsia"},{"key":"235_CR28","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1528-1167.2007.01429.x","volume":"49","author":"W Nasreddine","year":"2008","unstructured":"Nasreddine W, Beydoun A (2008) Valproate-induced thrombocytopenia: a prospective monotherapy study. Epilepsia 49:438\u2013445","journal-title":"Epilepsia"},{"key":"235_CR29","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3171\/jns.1983.58.5.0672","volume":"58","author":"JB North","year":"1983","unstructured":"North JB, Penhall RK, Hanieh A, Frewin DB, Taylor WB (1983) Phenytoin and postoperative epilepsy. A double-blind study. J Neurosurg 58:672\u2013677","journal-title":"J Neurosurg"},{"key":"235_CR30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11060-004-2338-2","volume":"72","author":"S Oberndorfer","year":"2005","unstructured":"Oberndorfer S, Piribauer M, Marosi C, Lahrmann H, Hitzenberger P, Grisold W (2005) P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy. J Neurooncol 72:255\u2013260","journal-title":"J Neurooncol"},{"key":"235_CR31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1358\/mf.2003.25.2.723686","volume":"25","author":"PN Patsalos","year":"2003","unstructured":"Patsalos PN (2003) The pharmacokinetic characteristics of levetiracetam. Methods Find Exp Clin Pharmacol 25:123\u2013129","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"235_CR32","doi-asserted-by":"crossref","first-page":"704","DOI":"10.2165\/00003088-200443110-00002","volume":"43","author":"PN Patsalos","year":"2004","unstructured":"Patsalos PN (2004) Clinical pharmacokinetics of levetiracetam. Clin Pharmacokinet 43:704\u2013724","journal-title":"Clin Pharmacokinet"},{"issue":"suppl 9","key":"235_CR33","first-page":"S7","volume":"40","author":"E Perucca","year":"1990","unstructured":"Perucca E (1990) The clinical pharmacokinetics of the new antiepileptic drugs. Epilepsia 40(suppl 9):S7\u2013S13","journal-title":"Epilepsia"},{"key":"235_CR34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2174\/157488408785747656","volume":"3","author":"S Pursche","year":"2008","unstructured":"Pursche S, Schleyer E, von Bonin M, Ehninger G, Said SM, Prondzinsky R, Illmer T, Wang Y, Hosius C, Nikolova Z, Bornh\u00e4user M, Dresemann G (2008) Influence of enzyme-inducing antiepileptic drugs on trough level of imatinib in glioblastoma patients. Curr Clin Pharmacol 3:198\u2013203","journal-title":"Curr Clin Pharmacol"},{"key":"235_CR35","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.eplepsyres.2009.02.016","volume":"85","author":"WE Rosenfeld","year":"2009","unstructured":"Rosenfeld WE, Benbadis S, Edrich P, Tassinari CA, Hirsch E (2009) Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies. Epilepsy Res 85:72\u201380","journal-title":"Epilepsy Res"},{"key":"235_CR36","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1517\/13543784.8.7.1103","volume":"8","author":"SC Schachter","year":"1999","unstructured":"Schachter SC (1999) Oxcarbazepine: current status and clinical applications. Expert Opin Investig Drugs 8:1103\u20131112","journal-title":"Expert Opin Investig Drugs"},{"key":"235_CR37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO, European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459\u2013466","journal-title":"Lancet Oncol"},{"key":"235_CR38","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0014-2999(99)00764-5","volume":"387","author":"Z Szupera","year":"2000","unstructured":"Szupera Z, Mezei Z, Kis B, Gecse A, V\u00e9csei L, Telegdy G (2000) The effects of valproate on the arachidonic acid metabolism of rat brain microvessels and of platelets. Eur J Pharmacol 387:205\u2013210","journal-title":"Eur J Pharmacol"},{"key":"235_CR39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1046\/j.1535-7597.2002.00038.x","volume":"2","author":"NR Temkin","year":"2002","unstructured":"Temkin NR (2002) Prophylactic anticonvulsants after neurosurgery. Epilepsy Curr 2:105\u2013107","journal-title":"Epilepsy Curr"},{"key":"235_CR40","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1474-4422(07)70103-5","volume":"6","author":"MS Breemen van","year":"2007","unstructured":"van Breemen MS, Wilms EB, Vecht CJ (2007) Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol 6:421\u2013430","journal-title":"Lancet Neurol"},{"key":"235_CR41","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00415-009-5156-9","volume":"256","author":"MS Breemen van","year":"2009","unstructured":"van Breemen MS, Rijsman RM, Taphoorn MJ, Walchenbach R, Zwinkels H, Vecht CJ (2009) Efficacy of anti-epileptic drugs in patients with gliomas and seizures. J Neurol 256:1519\u20131526","journal-title":"J Neurol"},{"key":"235_CR42","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1474-4422(03)00435-6","volume":"2","author":"CJ Vecht","year":"2003","unstructured":"Vecht CJ, Wagner GL, Wilms EB (2003) Interactions between antiepileptic and chemotherapeutic drugs. Lancet Neurol 2:404\u2013409","journal-title":"Lancet Neurol"},{"key":"235_CR43","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/00019052-199612000-00005","volume":"9","author":"JG Villemure","year":"1996","unstructured":"Villemure JG, de Tribolet N (1996) Epilepsy in patients with central nervous system tumors. Curr Opin Neurol 9:424\u2013428","journal-title":"Curr Opin Neurol"},{"key":"235_CR44","first-page":"589","volume":"66","author":"K Villikka","year":"1999","unstructured":"Villikka K, Kivist\u00f6 KT, M\u00e4enp\u00e4\u00e4 H, Joensuu H, Neuvonen PJ (1999) Cytochrome P450-inducing antiepileptics increase the clearance of vincristine in patients with brain tumors. Clin Pharmacol Ther 66:589\u2013593","journal-title":"Clin Pharmacol Ther"},{"key":"235_CR45","unstructured":"Wagner GL, Wilms EB, Vecht ChJ (2002) Levetiracetam: an anti-epileptic drug with interesting pharmacokinetic properties. Ned Tijdschr Geneeskd. 146:1218\u20131221 (Review: Dutch)"},{"key":"235_CR46","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S1059-1311(03)00096-7","volume":"12","author":"GL Wagner","year":"2003","unstructured":"Wagner GL, Wilms EB, Van Donselaar CA, Vecht ChJ (2003) Levetiracetam: preliminary experience in patients with primary brain tumours. Seizure 12:585\u2013586","journal-title":"Seizure"},{"key":"235_CR47","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00001622-200205000-00008","volume":"14","author":"PY Wen","year":"2002","unstructured":"Wen PY, Marks PW (2002) Medical management of patients with brain tumors. Curr Opin Oncol 14:299\u2013307","journal-title":"Curr Opin Oncol"},{"key":"235_CR48","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.clinthera.2008.08.011","volume":"30","author":"KY Yap","year":"2008","unstructured":"Yap KY, Chui WK, Chan A (2008) Drug interactions between chemotherapeutic regimens and antiepileptics. Clin Ther 30:1385\u20131407","journal-title":"Clin Ther"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-010-0235-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-010-0235-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-010-0235-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T04:19:41Z","timestamp":1559362781000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-010-0235-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,6]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["235"],"URL":"https:\/\/doi.org\/10.1007\/s11060-010-0235-4","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,6]]}}}